Adults 18 to 65, any sex, with Fibromyalgia or Neck Pain. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Tampa Scale of KinesiophobiaPrimary· 4-8 minutes
Based on a four-point Likert type, this scale contains 17 items that evaluate fear and anxiety related to physical activity. A total score of greater than 37 is accepted as statistically significant and interpreted as a high level of kinesiophobia. Minimal and maximal scores could be between 17-68 points. Higher scores indicate higher levels of kinesiophobia.
Group
Value
95% CI
Fibromyalgia Syndrome
41.70
± 6.30
Chronic Neck Pain
38.33
± 7.98
Healthy Controls
30.83
± 8.84
International Physical Activity Questionnaire Short FormPrimary· 5-10 minutes
This questionnaire consists of seven items that measure the duration of the participants' physical activity, walking and sitting within the last seven days in the metabolic equivalent (MET)-min/week unit. 3 or more days of vigorous activity of at least 20 minutes per day or 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day or 5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 600 MET-minutes/week are proposed to be moderate level. Vigorous-intensity activity on at least 3 da
Group
Value
95% CI
Fibromyalgia Syndrome
21
Chronic Neck Pain
14
Healthy Controls
7
Fibromyalgia Syndrome
7
Chronic Neck Pain
11
Healthy Controls
16
Fibromyalgia Syndrome
2
Chronic Neck Pain
5
Healthy Controls
7
Beck Depression InventoryPrimary· 10 minutes
This is a 21-item questionnaire that investigates the characteristic attitudes and symptoms of depression. A score of 10 or higher indicates depression. Minimal and maximal scores can be 0-63 points. Higher scores indicate higher levels of depression.
Fibromyalgia Impact Questionnaire aims to evaluate the arthritis symptoms and functional status of patients with fibromyalgia syndrome through 21 questions that inquire about physical functions, work-related situations, depression, anxiety, waking up tired, pain, stiffness, and fatigue. Higher scores indicate greater impact of fibromyalgia on functioning. Final score should range from 0 to 80.
Group
Value
95% CI
Fibromyalgia Syndrome
49.79
± 22.60
Chronic Neck Pain
44.44
± 15.71
Healthy Controls
13.79
± 10.17
Neck Pain Disability IndexPrimary· 5-8 minutes
This index consists of 20 questions that assess severity of neck pain and the extent to which the pain affects the social, professional and daily activities of patients.Final score should range from 0 to 100. Higher scores indicate greater levels of disability.
Group
Value
95% CI
Chronic Neck Pain
49.06
± 21.65
Healthy Controls
6.16
± 10.21
Visual Analog Scale for the Evaluation of PainPrimary· 0.5 minutes
For this evaluation, the patient is asked to mark his/her severity of pain on a horizontal 100-mm line with 0 on one end representing no pain and 100 on the other end represent very severe pain. Higher scores indicate higher levels of pain intensity.
Group
Value
95% CI
Fibromyalgia Syndrome
75.83
± 27.26
Chronic Neck Pain
50.33
± 23.85
Healthy Controls
0
± 0
Visual Analog Scale for the Evaluation of FatiguePrimary· 0.5 minutes
For this evaluation, the patient is asked to mark his/her severity of fatigue on a horizontal 100-mm line with 0 on one end representing no fatigue and 100 on the other end represent very severe fatigue.
Group
Value
95% CI
Fibromyalgia Syndrome
74.66
± 28.37
Chronic Neck Pain
64.33
± 24.59
Healthy Controls
41.66
± 23.05
Sponsor's own description
Kinesiophobia which is described as fear of movement reduces physical activity levels and increases the risk of chronic pain. The investigators consider that kinesiophobia levels are higher in patients with fibromyalgia syndrome and chronic neck pain so that physical activity levels are lower in this patient groups. Because there are not enough studies, the investigators aimed to evaluate kinesiophobia and physical activity levels in this patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aksaray University Training and Research Hospital
Last refreshed: 31 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778801.